Showing results (131-140 of 370) with videos related to
Sort By:
Pageof 37
Antibiotics (Basel, Switzerland)|September 23, 2022
Do Different Sutures with Triclosan Have Different Antimicrobial Activities? A Pharmacodynamic ApproachFrederic C Daoud, Fatima M'Zali, Arnaud Zabala, et al.Drug Safety|September 2, 2011
The case-population study design: an analysis of its application in pharmacovigilanceHélène Théophile, Joan-Ramon Laporte, Nicholas Moore, et al.Fundamental & Clinical Pharmacology|October 16, 2004
Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis modelAnwar Umar, Michel Boisseau, Abdiryim Yusup, et al.Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|August 4, 2007
[Study on mechanism of abnormal savda munziq flavonoids in induction of apoptosis of Hep2 cells]Abdiryim Yusup, Halmurat Upur, Xirali Tursun, et al.Drug Safety|May 26, 2018
Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database SampleMai Duong, Abdelilah Abouelfath, Regis Lassalle, et al.Thrombosis Research|February 14, 2006
Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivoIbadet Tohti, Maynur Tursun, Anwar Umar, et al.Journal of Ethnopharmacology|December 3, 2014
Effect of traditional Uyghur medicine abnormal Savda Munziq extract on rabbit platelet aggregation in vitro and rat arteriovenous shunt thrombosis in vivoAnwar Umar, Wuliya Yimin, Ibadet Tohti, et al.Pharmacoepidemiology and Drug Safety|June 29, 2010
Factors associated with persistence of cholinesterase inhibitor treatments in the elderlyAntoine Pariente, Marion Pinet, Yola Moride, et al.Methodsx|April 24, 2020
Secondary prevention of acute coronary syndrome with antiplatelet agents in real life: A high-dimensional propensity score matched cohort study in the French National claims databasePatrick Blin, Caroline Dureau-Pournin, Jérémy Jové, et al.British Journal of Clinical Pharmacology|December 18, 2003
Differences between clinical trials and postmarketing useKarin Martin, Bernard Bégaud, Philippe Latry, et al.Pageof 37